<b>Background/Objectives</b>: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is linked to poorer overall survival and a higher risk of brain metastases compared to HER2-negative breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.